NCBI Home Page NCBI Site Search page NCBI Guide that lists and describes the NCBI resources
Conserved domains on  [gi|495178532|ref|WP_007903323|]
View 

diacylglycerol kinase family protein [Leyella stercorea]

Protein Classification

diacylglycerol/lipid kinase family protein( domain architecture ID 11446635)

diacylglycerol/lipid kinase family protein may catalyze the ATP-dependent phosphorylation of diacylglycerol and/or other lipids, and is involved in the phospholipid biosynthetic process

CATH:  3.40.50.10330
EC:  2.7.1.-
SCOP:  3001940

Graphical summary

 Zoom to residue level

show extra options »

Show site features     Horizontal zoom: ×

List of domain hits

Name Accession Description Interval E-value
LCB5 COG1597
Phosphatidylglycerol kinase, diacylglycerol kinase family [Lipid transport and metabolism, ...
1-291 6.93e-95

Phosphatidylglycerol kinase, diacylglycerol kinase family [Lipid transport and metabolism, General function prediction only];


:

Pssm-ID: 441205 [Multi-domain]  Cd Length: 295  Bit Score: 283.67  E-value: 6.93e-95
                         10        20        30        40        50        60        70        80
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 495178532   1 MKKKAIFIINLISGTSDKAAIPELIEQLLDKEKFEYEIAITQYAGHASEIASKAKDANVDLVVAVGGDGTVNEVARAIVH 80
Cdd:COG1597    1 AMMRALLIVNPASGRGRAARLLERLVAALRAAGLEVEVLETESPGDATELAREAAAEGADLVVAAGGDGTVNEVANGLAG 80
                         90       100       110       120       130       140       150       160
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 495178532  81 SNTALGIIPCGSGNGLARHLQLPINVKKSIEILNTFEVRDLDYGIINGYPFFCTCGMGFDAFISLKFAEAGKR--GPLTY 158
Cdd:COG1597   81 TGPPLGILPLGTGNDFARALGIPLDPEAALEALLTGRTRRIDLGRVNGRYFLNVAGIGFDAEVVERANRALKRrlGKLAY 160
                        170       180       190       200       210       220       230       240
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 495178532 159 IENVLREGLKYEPETYTVMADDETSLHKAFLISCANASQYGNNAYIAPQASMSDGLMDVIIMEPFGLIDAPQISIEMFNK 238
Cdd:COG1597  161 VLAALRALLRYRPFRLRIELDGEEIEGEALLVAVGNGPYYGGGLRLAPDASLDDGLLDVVVVRPLSRLRLLRLLPRLLRG 240
                        250       260       270       280       290
                 ....*....|....*....|....*....|....*....|....*....|...
gi 495178532 239 TLDkNNSKIKTFRCKKLCVHRHSPGAIHYDGDPVMTGADIDVELKPKGIKIVV 291
Cdd:COG1597  241 RHL-RHPGVRYFRAREVEIESDRPLPVQLDGEPLGLATPLEFEVLPGALRVLV 292
 
Name Accession Description Interval E-value
LCB5 COG1597
Phosphatidylglycerol kinase, diacylglycerol kinase family [Lipid transport and metabolism, ...
1-291 6.93e-95

Phosphatidylglycerol kinase, diacylglycerol kinase family [Lipid transport and metabolism, General function prediction only];


Pssm-ID: 441205 [Multi-domain]  Cd Length: 295  Bit Score: 283.67  E-value: 6.93e-95
                         10        20        30        40        50        60        70        80
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 495178532   1 MKKKAIFIINLISGTSDKAAIPELIEQLLDKEKFEYEIAITQYAGHASEIASKAKDANVDLVVAVGGDGTVNEVARAIVH 80
Cdd:COG1597    1 AMMRALLIVNPASGRGRAARLLERLVAALRAAGLEVEVLETESPGDATELAREAAAEGADLVVAAGGDGTVNEVANGLAG 80
                         90       100       110       120       130       140       150       160
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 495178532  81 SNTALGIIPCGSGNGLARHLQLPINVKKSIEILNTFEVRDLDYGIINGYPFFCTCGMGFDAFISLKFAEAGKR--GPLTY 158
Cdd:COG1597   81 TGPPLGILPLGTGNDFARALGIPLDPEAALEALLTGRTRRIDLGRVNGRYFLNVAGIGFDAEVVERANRALKRrlGKLAY 160
                        170       180       190       200       210       220       230       240
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 495178532 159 IENVLREGLKYEPETYTVMADDETSLHKAFLISCANASQYGNNAYIAPQASMSDGLMDVIIMEPFGLIDAPQISIEMFNK 238
Cdd:COG1597  161 VLAALRALLRYRPFRLRIELDGEEIEGEALLVAVGNGPYYGGGLRLAPDASLDDGLLDVVVVRPLSRLRLLRLLPRLLRG 240
                        250       260       270       280       290
                 ....*....|....*....|....*....|....*....|....*....|...
gi 495178532 239 TLDkNNSKIKTFRCKKLCVHRHSPGAIHYDGDPVMTGADIDVELKPKGIKIVV 291
Cdd:COG1597  241 RHL-RHPGVRYFRAREVEIESDRPLPVQLDGEPLGLATPLEFEVLPGALRVLV 292
PRK00861 PRK00861
putative lipid kinase; Reviewed
1-296 4.22e-38

putative lipid kinase; Reviewed


Pssm-ID: 234850 [Multi-domain]  Cd Length: 300  Bit Score: 137.83  E-value: 4.22e-38
                         10        20        30        40        50        60        70        80
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 495178532   1 MKKKAIFIINLISGTSDKAAIPELIEQLLDkEKFEYEIAITQYAGHASEIASKAKDANVDLVVAVGGDGTVNEVARAIVH 80
Cdd:PRK00861   1 MTRSACLIFNPVAGQGNPEVDLALIRAILE-PEMDLDIYLTTPEIGADQLAQEAIERGAELIIASGGDGTLSAVAGALIG 79
                         90       100       110       120       130       140       150       160
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 495178532  81 SNTALGIIPCGSGNGLARHLQLPINVKKSIEILNTFEVRDLDYGIINGYPFFCTCGMGFDA-FISLKFAEAGKR-GPLTY 158
Cdd:PRK00861  80 TDIPLGIIPRGTANAFAAALGIPDTIEEACRTILQGKTRRVDVAYCNGQPMILLAGIGFEAeTVEEADREAKNRfGILAY 159
                        170       180       190       200       210       220       230       240
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 495178532 159 IENVLREGLKYEPETYTVMADDETSLHKAFLISCANAsqygnnayiAPQASM----------SDGLMDVIIMEPFGLIDA 228
Cdd:PRK00861 160 ILSGLQQLRELESFEVEIETEDQIITTNAVAVTVANA---------APPTSVlaqgpgavipDDGLLDVTIVAPKNLAEA 230
                        250       260       270       280       290       300       310
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|.
gi 495178532 229 PQISIEMFNKTLDKNNSK---IKTFRCKKLCVHRHSPGAIHYDGDpVMTGADIDVELKPKGIKIVVNSQAD 296
Cdd:PRK00861 231 VAASYHLLQTALQGNPAErddIGYLRAKQVKITTDPPQKVVIDGE-VVGTTPIEIECLPRSLKVFAPLQAE 300
DAGK_cat pfam00781
Diacylglycerol kinase catalytic domain; Diacylglycerol (DAG) is a second messenger that acts ...
4-124 2.89e-36

Diacylglycerol kinase catalytic domain; Diacylglycerol (DAG) is a second messenger that acts as a protein kinase C activator. The catalytic domain is assumed from the finding of bacterial homologs. YegS is the Escherichia coli protein in this family whose crystal structure reveals an active site in the inter-domain cleft formed by four conserved sequence motifs, revealing a novel metal-binding site. The residues of this site are conserved across the family.


Pssm-ID: 425868 [Multi-domain]  Cd Length: 125  Bit Score: 127.32  E-value: 2.89e-36
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 495178532    4 KAIFIINLISGTSDKAAIPELIEQLLDKEKFEYEIAITQYAGHASEIASKAKDANVDLVVAVGGDGTVNEVARAIVHSNT 83
Cdd:pfam00781   1 KLLVIVNPKSGGGKGKKLLRKVRPLLNKAGVEVELVLTEGPGDALELAREAAEDGYDRIVVAGGDGTVNEVLNGLAGLAT 80
                          90       100       110       120
                  ....*....|....*....|....*....|....*....|...
gi 495178532   84 --ALGIIPCGSGNGLARHLQLPINVKKSIEILNTFEVRDLDYG 124
Cdd:pfam00781  81 rpPLGIIPLGTGNDFARALGIPGDPEEALEAILKGQTRPVDVG 123
TIGR00147 TIGR00147
lipid kinase, YegS/Rv2252/BmrU family; The E. coli member of this family, YegS has been ...
3-291 3.08e-33

lipid kinase, YegS/Rv2252/BmrU family; The E. coli member of this family, YegS has been purified and shown to have phosphatidylglycerol kinase activity. The member from M. tuberculosis, Rv2252, has diacylglycerol kinase activity. BmrU from B. subtilis is in an operon with multidrug efflux transporter Bmr, but is uncharacterized. [Unknown function, Enzymes of unknown specificity]


Pssm-ID: 161732 [Multi-domain]  Cd Length: 293  Bit Score: 124.54  E-value: 3.08e-33
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 495178532    3 KKAIFIINLISGTS-DKAAIPELIeQLLDKEKFEYEIAITQYAGHASEIASKAKDANVDLVVAVGGDGTVNEVARAI--V 79
Cdd:TIGR00147   2 AEAPAILNPTAGKSnDNKPLREVI-MLLREEGMEIHVRVTWEKGDAARYVEEARKFGVDTVIAGGGDGTINEVVNALiqL 80
                          90       100       110       120       130       140       150       160
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 495178532   80 HSNTALGIIPCGSGNGLARHLQLPINVKKSIEILNTFEVRDLDYGIING-YPFFCTCGMGFDAFISLKFAEAGKR--GPL 156
Cdd:TIGR00147  81 DDIPALGILPLGTANDFARSLGIPEDLDKAAKLVIAGDARAIDMGQVNKqYCFINMAGGGFGTEITTETPEKLKAalGSL 160
                         170       180       190       200       210       220       230       240
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 495178532  157 TYIENVLREGLKYEPETYTVMADDETSLHKAFLISCANASQYGNNAYIAPQASMSDGLMDVIIMEPFGLIDApQISIEMF 236
Cdd:TIGR00147 161 SYILSGLMRMDTLQPFRCEIRGEGEHWQGEAVVFLVGNGRQAGGGQKLAPDASINDGLLDLRIFTNDNLLPA-LVLTLMS 239
                         250       260       270       280       290
                  ....*....|....*....|....*....|....*....|....*....|....*
gi 495178532  237 NKTLDKNNSKIKTFRCKKLCVHRHSPGAIHYDGDPvMTGADIDVELKPKGIKIVV 291
Cdd:TIGR00147 240 DEGKHTDNPNIIYGKASRIDIQTPHKITFNLDGEP-LGGTPFHIEILPAHLRCRL 293
DAGKc smart00046
Diacylglycerol kinase catalytic domain (presumed); Diacylglycerol (DAG) is a second messenger ...
6-114 2.64e-12

Diacylglycerol kinase catalytic domain (presumed); Diacylglycerol (DAG) is a second messenger that acts as a protein kinase C activator. DAG can be produced from the hydrolysis of phosphatidylinositol 4,5-bisphosphate (PIP2) by a phosphoinositide-specific phospholipase C and by the degradation of phosphatidylcholine (PC) by a phospholipase C or the concerted actions of phospholipase D and phosphatidate phosphohydrolase. This domain is presumed to be the catalytic domain. Bacterial homologues areknown.


Pssm-ID: 214487 [Multi-domain]  Cd Length: 124  Bit Score: 63.08  E-value: 2.64e-12
                           10        20        30        40        50        60        70        80
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 495178532     6 IFIINLISGTSDkaaiPELIEQLLDKEKFEYEIAITQYAGHASEIASKAKDANVDLVVAVGGDGTVNEVARAIVHSN--- 82
Cdd:smart00046   1 LVFVNPKSGGGK----GEKLLRKFRLLLNPRQVFDLTKKGPAVALVIFRDVPDFNRVLVCGGDGTVGWVLNALDKRElpl 76
                           90       100       110
                   ....*....|....*....|....*....|....
gi 495178532    83 --TALGIIPCGSGNGLARHLQLPINVKKSIEILN 114
Cdd:smart00046  77 pePPVAVLPLGTGNDLARSLGWGGGYDGEKLLKT 110
GlyDH-like cd08550
Glycerol_dehydrogenase-like; This family contains glycerol dehydrogenase (GlyDH)-like proteins. ...
11-78 5.15e-03

Glycerol_dehydrogenase-like; This family contains glycerol dehydrogenase (GlyDH)-like proteins. Glycerol dehydrogenases (GlyDH) is a key enzyme in the glycerol dissimilation pathway. In anaerobic conditions, many microorganisms utilize glycerol as a source of carbon through coupled oxidative and reductive pathways. One of the pathways involves the oxidation of glycerol to dihydroxyacetone with the reduction of NAD+ to NADH catalyzed by glycerol dehydrogenases. Dihydroxyacetone is then phosphorylated by dihydroxyacetone kinase and enters the glycolytic pathway for further degradation. The activity of GlyDH is zinc-dependent; the zinc ion plays a role in stabilizing an alkoxide intermediate at the active site. Some subfamilies have yet to be characterized.


Pssm-ID: 341480 [Multi-domain]  Cd Length: 347  Bit Score: 38.29  E-value: 5.15e-03
                         10        20        30        40        50        60        70
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....
gi 495178532  11 LISG-TSDKAAIPELIEQLlDKEKFEYEIAItqYAGHASE-----IASKAKDANVDLVVAVGGdGTVNEVARAI 78
Cdd:cd08550   27 IIGGkTALEAVGEKLEKSL-EEAGIDYEVEV--FGGECTEenierLAEKAKEEGADVIIGIGG-GKVLDTAKAV 96
 
Name Accession Description Interval E-value
LCB5 COG1597
Phosphatidylglycerol kinase, diacylglycerol kinase family [Lipid transport and metabolism, ...
1-291 6.93e-95

Phosphatidylglycerol kinase, diacylglycerol kinase family [Lipid transport and metabolism, General function prediction only];


Pssm-ID: 441205 [Multi-domain]  Cd Length: 295  Bit Score: 283.67  E-value: 6.93e-95
                         10        20        30        40        50        60        70        80
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 495178532   1 MKKKAIFIINLISGTSDKAAIPELIEQLLDKEKFEYEIAITQYAGHASEIASKAKDANVDLVVAVGGDGTVNEVARAIVH 80
Cdd:COG1597    1 AMMRALLIVNPASGRGRAARLLERLVAALRAAGLEVEVLETESPGDATELAREAAAEGADLVVAAGGDGTVNEVANGLAG 80
                         90       100       110       120       130       140       150       160
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 495178532  81 SNTALGIIPCGSGNGLARHLQLPINVKKSIEILNTFEVRDLDYGIINGYPFFCTCGMGFDAFISLKFAEAGKR--GPLTY 158
Cdd:COG1597   81 TGPPLGILPLGTGNDFARALGIPLDPEAALEALLTGRTRRIDLGRVNGRYFLNVAGIGFDAEVVERANRALKRrlGKLAY 160
                        170       180       190       200       210       220       230       240
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 495178532 159 IENVLREGLKYEPETYTVMADDETSLHKAFLISCANASQYGNNAYIAPQASMSDGLMDVIIMEPFGLIDAPQISIEMFNK 238
Cdd:COG1597  161 VLAALRALLRYRPFRLRIELDGEEIEGEALLVAVGNGPYYGGGLRLAPDASLDDGLLDVVVVRPLSRLRLLRLLPRLLRG 240
                        250       260       270       280       290
                 ....*....|....*....|....*....|....*....|....*....|...
gi 495178532 239 TLDkNNSKIKTFRCKKLCVHRHSPGAIHYDGDPVMTGADIDVELKPKGIKIVV 291
Cdd:COG1597  241 RHL-RHPGVRYFRAREVEIESDRPLPVQLDGEPLGLATPLEFEVLPGALRVLV 292
PRK00861 PRK00861
putative lipid kinase; Reviewed
1-296 4.22e-38

putative lipid kinase; Reviewed


Pssm-ID: 234850 [Multi-domain]  Cd Length: 300  Bit Score: 137.83  E-value: 4.22e-38
                         10        20        30        40        50        60        70        80
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 495178532   1 MKKKAIFIINLISGTSDKAAIPELIEQLLDkEKFEYEIAITQYAGHASEIASKAKDANVDLVVAVGGDGTVNEVARAIVH 80
Cdd:PRK00861   1 MTRSACLIFNPVAGQGNPEVDLALIRAILE-PEMDLDIYLTTPEIGADQLAQEAIERGAELIIASGGDGTLSAVAGALIG 79
                         90       100       110       120       130       140       150       160
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 495178532  81 SNTALGIIPCGSGNGLARHLQLPINVKKSIEILNTFEVRDLDYGIINGYPFFCTCGMGFDA-FISLKFAEAGKR-GPLTY 158
Cdd:PRK00861  80 TDIPLGIIPRGTANAFAAALGIPDTIEEACRTILQGKTRRVDVAYCNGQPMILLAGIGFEAeTVEEADREAKNRfGILAY 159
                        170       180       190       200       210       220       230       240
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 495178532 159 IENVLREGLKYEPETYTVMADDETSLHKAFLISCANAsqygnnayiAPQASM----------SDGLMDVIIMEPFGLIDA 228
Cdd:PRK00861 160 ILSGLQQLRELESFEVEIETEDQIITTNAVAVTVANA---------APPTSVlaqgpgavipDDGLLDVTIVAPKNLAEA 230
                        250       260       270       280       290       300       310
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|.
gi 495178532 229 PQISIEMFNKTLDKNNSK---IKTFRCKKLCVHRHSPGAIHYDGDpVMTGADIDVELKPKGIKIVVNSQAD 296
Cdd:PRK00861 231 VAASYHLLQTALQGNPAErddIGYLRAKQVKITTDPPQKVVIDGE-VVGTTPIEIECLPRSLKVFAPLQAE 300
DAGK_cat pfam00781
Diacylglycerol kinase catalytic domain; Diacylglycerol (DAG) is a second messenger that acts ...
4-124 2.89e-36

Diacylglycerol kinase catalytic domain; Diacylglycerol (DAG) is a second messenger that acts as a protein kinase C activator. The catalytic domain is assumed from the finding of bacterial homologs. YegS is the Escherichia coli protein in this family whose crystal structure reveals an active site in the inter-domain cleft formed by four conserved sequence motifs, revealing a novel metal-binding site. The residues of this site are conserved across the family.


Pssm-ID: 425868 [Multi-domain]  Cd Length: 125  Bit Score: 127.32  E-value: 2.89e-36
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 495178532    4 KAIFIINLISGTSDKAAIPELIEQLLDKEKFEYEIAITQYAGHASEIASKAKDANVDLVVAVGGDGTVNEVARAIVHSNT 83
Cdd:pfam00781   1 KLLVIVNPKSGGGKGKKLLRKVRPLLNKAGVEVELVLTEGPGDALELAREAAEDGYDRIVVAGGDGTVNEVLNGLAGLAT 80
                          90       100       110       120
                  ....*....|....*....|....*....|....*....|...
gi 495178532   84 --ALGIIPCGSGNGLARHLQLPINVKKSIEILNTFEVRDLDYG 124
Cdd:pfam00781  81 rpPLGIIPLGTGNDFARALGIPGDPEEALEAILKGQTRPVDVG 123
TIGR00147 TIGR00147
lipid kinase, YegS/Rv2252/BmrU family; The E. coli member of this family, YegS has been ...
3-291 3.08e-33

lipid kinase, YegS/Rv2252/BmrU family; The E. coli member of this family, YegS has been purified and shown to have phosphatidylglycerol kinase activity. The member from M. tuberculosis, Rv2252, has diacylglycerol kinase activity. BmrU from B. subtilis is in an operon with multidrug efflux transporter Bmr, but is uncharacterized. [Unknown function, Enzymes of unknown specificity]


Pssm-ID: 161732 [Multi-domain]  Cd Length: 293  Bit Score: 124.54  E-value: 3.08e-33
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 495178532    3 KKAIFIINLISGTS-DKAAIPELIeQLLDKEKFEYEIAITQYAGHASEIASKAKDANVDLVVAVGGDGTVNEVARAI--V 79
Cdd:TIGR00147   2 AEAPAILNPTAGKSnDNKPLREVI-MLLREEGMEIHVRVTWEKGDAARYVEEARKFGVDTVIAGGGDGTINEVVNALiqL 80
                          90       100       110       120       130       140       150       160
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 495178532   80 HSNTALGIIPCGSGNGLARHLQLPINVKKSIEILNTFEVRDLDYGIING-YPFFCTCGMGFDAFISLKFAEAGKR--GPL 156
Cdd:TIGR00147  81 DDIPALGILPLGTANDFARSLGIPEDLDKAAKLVIAGDARAIDMGQVNKqYCFINMAGGGFGTEITTETPEKLKAalGSL 160
                         170       180       190       200       210       220       230       240
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 495178532  157 TYIENVLREGLKYEPETYTVMADDETSLHKAFLISCANASQYGNNAYIAPQASMSDGLMDVIIMEPFGLIDApQISIEMF 236
Cdd:TIGR00147 161 SYILSGLMRMDTLQPFRCEIRGEGEHWQGEAVVFLVGNGRQAGGGQKLAPDASINDGLLDLRIFTNDNLLPA-LVLTLMS 239
                         250       260       270       280       290
                  ....*....|....*....|....*....|....*....|....*....|....*
gi 495178532  237 NKTLDKNNSKIKTFRCKKLCVHRHSPGAIHYDGDPvMTGADIDVELKPKGIKIVV 291
Cdd:TIGR00147 240 DEGKHTDNPNIIYGKASRIDIQTPHKITFNLDGEP-LGGTPFHIEILPAHLRCRL 293
PRK12361 PRK12361
hypothetical protein; Provisional
2-296 9.01e-29

hypothetical protein; Provisional


Pssm-ID: 183473 [Multi-domain]  Cd Length: 547  Bit Score: 116.26  E-value: 9.01e-29
                         10        20        30        40        50        60        70        80
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 495178532   2 KKKAIFIINLISGTSDKAAIPELIEQLLdKEKFEYEIAITQYAGHASEIASKAKDANVDLVVAVGGDGTVNEVARAIVHS 81
Cdd:PRK12361 242 HKRAWLIANPVSGGGKWQEYGEQIQREL-KAYFDLTVKLTTPEISAEALAKQARKAGADIVIACGGDGTVTEVASELVNT 320
                         90       100       110       120       130       140       150       160
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 495178532  82 NTALGIIPCGSGNGLARHL----QLPINVKKSIEILNTFEVRDLDYGIINGYPFFCTCGMGFDAfislKFAEAGKR---- 153
Cdd:PRK12361 321 DITLGIIPLGTANALSHALfglgSKLIPVEQACDNIIQGHTQRIDTARCNDRLMLLLVGIGFEQ----KMIESADRerkn 396
                        170       180       190       200       210       220       230       240
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 495178532 154 --GPLTYIENVLREGLKYEPETYTVMADDETSLH---KAFLIscANASQY------GNNayiAPQasMSDGLMDVIIMEP 222
Cdd:PRK12361 397 alGQLAYLDGLWRAVNENETLTLTVTLDDAEPQTistHSLVV--ANAAPFtsllaqGGG---EPN--MTDGLLDITWLDS 469
                        250       260       270       280       290       300       310
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....
gi 495178532 223 FGLIDAPQISI-EMFNKTLDKN--NSKIKTFRCKKlcVHRHSPGAIHY--DGDpVMTGADIDVELKPKGIKIVVNSQAD 296
Cdd:PRK12361 470 GGEPGEQLLSLaELALSGLGKEpeANKVHHAHAKK--VTISSQKPIKYviDGE-LFEDEDLTIEVQPASLKVFVPYQEI 545
PRK13057 PRK13057
lipid kinase;
23-221 1.19e-23

lipid kinase;


Pssm-ID: 183857 [Multi-domain]  Cd Length: 287  Bit Score: 98.45  E-value: 1.19e-23
                         10        20        30        40        50        60        70        80
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 495178532  23 ELIEQLLDKEKFEYEIAITQYAGHASEIASKAKDAnVDLVVAVGGDGTVNEVARAIVHSNTALGIIPCGSGNGLARHLQL 102
Cdd:PRK13057  16 AAARAALEAAGLELVEPPAEDPDDLSEVIEAYADG-VDLVIVGGGDGTLNAAAPALVETGLPLGILPLGTANDLARTLGI 94
                         90       100       110       120       130       140       150       160
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 495178532 103 PINVKKSIEILNTFEVRDLDYGIINGYPFFCTCGMGFDAFISLKF-AEAGKR-GPLTYIENVLREGLKYEPETYTVMADD 180
Cdd:PRK13057  95 PLDLEAAARVIATGQVRRIDLGWVNGHYFFNVASLGLSAELARRLtKELKRRwGTLGYAIAALRVLRRSRPFTAEIEHDG 174
                        170       180       190       200
                 ....*....|....*....|....*....|....*....|.
gi 495178532 181 ETSLHKAFLISCANASQYGNNAYIAPQASMSDGLMDVIIME 221
Cdd:PRK13057 175 RTERVKTLQVAVGNGRYYGGGMTVAHDATIDDGRLDLYSLE 215
PRK13059 PRK13059
putative lipid kinase; Reviewed
3-291 4.69e-21

putative lipid kinase; Reviewed


Pssm-ID: 183858  Cd Length: 295  Bit Score: 91.64  E-value: 4.69e-21
                         10        20        30        40        50        60        70        80
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 495178532   3 KKAIFIINLISGTSdkaAIPELIEQLLDKEKfEYEIAITQY---AGHASEIASKAKDANVDLVVAVGGDGTVNEVARAIV 79
Cdd:PRK13059   2 KKVKFIYNPYSGEN---AIISELDKVIRIHQ-EKGYLVVPYrisLEYDLKNAFKDIDESYKYILIAGGDGTVDNVVNAMK 77
                         90       100       110       120       130       140       150       160
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 495178532  80 HSNTAL--GIIPCGSGNGLARHLQLPINVKKSIEILNTFEVRDLDYGIINGYPFFCTCGMGFDAFISLKFAEAGKR--GP 155
Cdd:PRK13059  78 KLNIDLpiGILPVGTANDFAKFLGMPTDIGEACEQILKSKPKKVDLGKINDKYFINVASTGLFTDVSQKTDVNLKNtiGK 157
                        170       180       190       200       210       220       230       240
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 495178532 156 LTYIENVLREGLKYEPETYTVMADDETSLHKAFLISCANASQYGN--NAYiapQASMSDGLMDVIIMEPFGLIDAPQISI 233
Cdd:PRK13059 158 LAYYLKGLEELPNFRKLKVKVTSEEVNFDGDMYLMLVFNGQTAGNfnLAY---KAEVDDGLLDVIIIKACPIIDLIPLFI 234
                        250       260       270       280       290       300
                 ....*....|....*....|....*....|....*....|....*....|....*....|
gi 495178532 234 EMFNKTLDKNNSKIKTFRCKKLCVHRHSPGAIHYDGDpvmTGAD--IDVELKPKGIKIVV 291
Cdd:PRK13059 235 KVLKGEHLEDVNGLIYFKTDKLEIESNEEIVTDIDGE---RGPDfpLNIECIKGGLKVLG 291
PRK13054 PRK13054
lipid kinase; Reviewed
1-290 3.27e-20

lipid kinase; Reviewed


Pssm-ID: 237281 [Multi-domain]  Cd Length: 300  Bit Score: 89.16  E-value: 3.27e-20
                         10        20        30        40        50        60        70        80
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 495178532   1 MKKKAIFIINlisgtSDKAAIPELIE--QLLDKEKFEYEIAITQYAGHASEIASKAKDANVDLVVAVGGDGTVNEVARAI 78
Cdd:PRK13054   2 TFPKSLLILN-----GKSAGNEELREavGLLREEGHTLHVRVTWEKGDAARYVEEALALGVATVIAGGGDGTINEVATAL 76
                         90       100       110       120       130       140       150       160
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 495178532  79 VH----SNTALGIIPCGSGNGLARHLQLPINVKKSIEILNTFEVRDLDYGIINGYPFFCTcgM---GFDAFISLKFAEAG 151
Cdd:PRK13054  77 AQlegdARPALGILPLGTANDFATAAGIPLEPDKALKLAIEGRAQPIDLARVNDRTYFIN--MatgGFGTRVTTETPEKL 154
                        170       180       190       200       210       220       230       240
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 495178532 152 KR--GPLTYIENVLREGLKYEPETYTVMADDETSLHKAFLISCANASQYGNNAYIAPQASMSDGLMDVIIMEPFGlIDAP 229
Cdd:PRK13054 155 KAalGGVAYLIHGLMRMDTLKPDRCEIRGPDFHWQGDALVIGIGNGRQAGGGQQLCPEALINDGLLDLRILPAPQ-ELLP 233
                        250       260       270       280       290       300
                 ....*....|....*....|....*....|....*....|....*....|....*....|.
gi 495178532 230 QISIEMFNKTLDKNNskIKTFRCKKLCVHRHSPGAIHYDGDPVmTGADIDVELKPKGIKIV 290
Cdd:PRK13054 234 TLLSTLTGGSEDNPN--IIRARLPWLEIQAPHELTFNLDGEPL-SGRHFRIEVLPAALRCR 291
PRK13337 PRK13337
putative lipid kinase; Reviewed
3-221 3.29e-17

putative lipid kinase; Reviewed


Pssm-ID: 183982 [Multi-domain]  Cd Length: 304  Bit Score: 80.86  E-value: 3.29e-17
                         10        20        30        40        50        60        70        80
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 495178532   3 KKAIFIINLISGTSD-KAAIPELIEQLldkEKFEYEIAI--TQYAGHASEIASKAKDANVDLVVAVGGDGTVNEVARAIV 79
Cdd:PRK13337   2 KRARIIYNPTSGRELfKKNLPDVLQKL---EQAGYETSAhaTTGPGDATLAAERAVERKFDLVIAAGGDGTLNEVVNGIA 78
                         90       100       110       120       130       140       150       160
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 495178532  80 -HSN-TALGIIPCGSGNGLARHLQLPINVKKSIEILNTFEVRDLDYGIINGYPFFCTCGMG------FDAFISLKFAeag 151
Cdd:PRK13337  79 eKENrPKLGIIPVGTTNDFARALHVPRDIEKAADVIIEGHTVPVDIGKANNRYFINIAGGGrlteltYEVPSKLKTM--- 155
                        170       180       190       200       210       220       230
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....
gi 495178532 152 kRGPLTYienvLREGLKYEPETYTV---------MADDETSLhkaFLISCANAsqYGNNAYIAPQASMSDGLMDVIIME 221
Cdd:PRK13337 156 -LGQLAY----YLKGIEMLPSLKATdvrieydgkLFQGEIML---FLLGLTNS--VGGFEKLAPDASLDDGYFDLIIVK 224
PRK11914 PRK11914
diacylglycerol kinase; Reviewed
44-295 3.41e-17

diacylglycerol kinase; Reviewed


Pssm-ID: 237021 [Multi-domain]  Cd Length: 306  Bit Score: 80.99  E-value: 3.41e-17
                         10        20        30        40        50        60        70        80
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 495178532  44 AGHASEIASKAKDANVDLVVAVGGDGTVNEVARAIVHSNTALGIIPCGSGNGLARHLQLPI-NVKKSIEILNTFEVRDLD 122
Cdd:PRK11914  50 AHDARHLVAAALAKGTDALVVVGGDGVISNALQVLAGTDIPLGIIPAGTGNDHAREFGIPTgDPEAAADVIVDGWTETVD 129
                         90       100       110       120       130       140       150       160
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 495178532 123 YGIINGYP-----FFCTCGMGFDAFISlkfaEAGKR-----GPLTYIENVLREGLKYEPETYTVMADD-ETSLHKAFLIS 191
Cdd:PRK11914 130 LGRIQDDDgivkwFGTVAATGFDSLVT----DRANRmrwphGRMRYNLAMLAELSKLRPLPFRLVLDGtEEIVTDLTLAA 205
                        170       180       190       200       210       220       230       240
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 495178532 192 CANASQYGNNAYIAPQASMSDGLMDVIIMEpfgliDAPQISIEMFNKTLDK----NNSKIKTFRCKKlcVHRHSPGAIHY 267
Cdd:PRK11914 206 FGNTRSYGGGMLICPNADHTDGLLDITMVQ-----SASRTRLLRLFPTVFKgthvELDEVSTARAKT--VHVECPGINAY 278
                        250       260
                 ....*....|....*....|....*....
gi 495178532 268 -DGDPVMTgADIDVELKPKGIKIVVNSQA 295
Cdd:PRK11914 279 aDGDFACP-LPAEISAVPGALQILRPRPG 306
PRK13055 PRK13055
putative lipid kinase; Reviewed
1-323 3.07e-16

putative lipid kinase; Reviewed


Pssm-ID: 237282 [Multi-domain]  Cd Length: 334  Bit Score: 78.49  E-value: 3.07e-16
                         10        20        30        40        50        60        70        80
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 495178532   1 MKKKAIFIINLISGtsdKAAIPELIEQLLDK-EKFEYE---IAITQYAGHASEIASKAKDANVDLVVAVGGDGTVNEVAR 76
Cdd:PRK13055   1 MQKRARLIYNPTSG---QEIMKKNVADILDIlEQAGYEtsaFQTTPEPNSAKNEAKRAAEAGFDLIIAAGGDGTINEVVN 77
                         90       100       110       120       130       140       150       160
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 495178532  77 AI--VHSNTALGIIPCGSGNGLARHLQLP-INVKKSIEILNTFEVRDLDYGIINGYPFFctcgmgfdafisLKFAEAGKR 153
Cdd:PRK13055  78 GIapLEKRPKMAIIPAGTTNDYARALKIPrDNPVEAAKVILKNQTIKMDIGRANEDKYF------------INIAAGGSL 145
                        170       180       190       200       210       220       230       240
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 495178532 154 GPLTYI--ENV---------LREGLKYEPETYTVMA----DDETSLHKAFLISCANASQYGNNAYIAPQASMSDGLMDVI 218
Cdd:PRK13055 146 TELTYSvpSQLksmfgylayLAKGAELLPRVSPVPVrityDEGVFEGKISMFFLALTNSVGGFEQIVPDAKLDDGKFTLI 225
                        250       260       270       280       290       300       310       320
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 495178532 219 IMEPFGLIDAPQISIEMFNKTLDKNNSKIKTFRCKKLCVHRHSPGA--IHYDGDpvmTGADIDVELK--PKGIKIVVNSQ 294
Cdd:PRK13055 226 IVKTANLFELLHLMALILNGGKHIDDPRVIYIKTSKLTIEPLGDDRlmVNLDGE---YGGDAPMTFEnlKQHIEFFANTD 302
                        330       340       350
                 ....*....|....*....|....*....|.
gi 495178532 295 A--DRNLRKPNALQNAATELFNEINIIREEI 323
Cdd:PRK13055 303 EisDDALTDELEIEEIAKKFAEEVEDLEQED 333
YegS_C pfam19279
YegS C-terminal NAD kinase beta sandwich-like domain; This entry represents the C-terminal ...
153-222 1.08e-12

YegS C-terminal NAD kinase beta sandwich-like domain; This entry represents the C-terminal domain found in the YegS protein. It is related to the beta sandwich domain of NAD kinases. The structure of YegS reveals a two-domain protein with the active site crevice found between the two domains. The C-terminal domain contains 13 beta-strands and two alpha-helices. The likely substrate for YegS is phosphatidylglycerol.


Pssm-ID: 437111  Cd Length: 158  Bit Score: 64.91  E-value: 1.08e-12
                          10        20        30        40        50        60        70
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 495178532  153 RGPLTYIENVLREGLKYEPETYTVMADDETSLHKAFLISCANASQYGNNAYIAPQASMSDGLMDVIIMEP 222
Cdd:pfam19279  22 PGALSYPAAALRALATFRPLRYRVTVDGEVREFSAALVAVANSGYYGGGMRIAPDARVDDGLLDVVVIEA 91
DAGKc smart00046
Diacylglycerol kinase catalytic domain (presumed); Diacylglycerol (DAG) is a second messenger ...
6-114 2.64e-12

Diacylglycerol kinase catalytic domain (presumed); Diacylglycerol (DAG) is a second messenger that acts as a protein kinase C activator. DAG can be produced from the hydrolysis of phosphatidylinositol 4,5-bisphosphate (PIP2) by a phosphoinositide-specific phospholipase C and by the degradation of phosphatidylcholine (PC) by a phospholipase C or the concerted actions of phospholipase D and phosphatidate phosphohydrolase. This domain is presumed to be the catalytic domain. Bacterial homologues areknown.


Pssm-ID: 214487 [Multi-domain]  Cd Length: 124  Bit Score: 63.08  E-value: 2.64e-12
                           10        20        30        40        50        60        70        80
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 495178532     6 IFIINLISGTSDkaaiPELIEQLLDKEKFEYEIAITQYAGHASEIASKAKDANVDLVVAVGGDGTVNEVARAIVHSN--- 82
Cdd:smart00046   1 LVFVNPKSGGGK----GEKLLRKFRLLLNPRQVFDLTKKGPAVALVIFRDVPDFNRVLVCGGDGTVGWVLNALDKRElpl 76
                           90       100       110
                   ....*....|....*....|....*....|....
gi 495178532    83 --TALGIIPCGSGNGLARHLQLPINVKKSIEILN 114
Cdd:smart00046  77 pePPVAVLPLGTGNDLARSLGWGGGYDGEKLLKT 110
PLN02958 PLN02958
diacylglycerol kinase/D-erythro-sphingosine kinase
3-100 1.91e-05

diacylglycerol kinase/D-erythro-sphingosine kinase


Pssm-ID: 215517 [Multi-domain]  Cd Length: 481  Bit Score: 46.01  E-value: 1.91e-05
                         10        20        30        40        50        60        70        80
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 495178532   3 KKAIFIINLISGTSDKAAI-PELIEQLLDKEKFEYEIAITQYAGHASEIASKAKDANVDLVVAVGGDGTVNEVARAIVHS 81
Cdd:PLN02958 112 KRLLVFVNPFGGKKSASKIfFDVVKPLLEDADIQLTIQETKYQLHAKEVVRTMDLSKYDGIVCVSGDGILVEVVNGLLER 191
                         90       100
                 ....*....|....*....|....*.
gi 495178532  82 ---NTA----LGIIPCGSGNGLARHL 100
Cdd:PLN02958 192 edwKTAiklpIGMVPAGTGNGMAKSL 217
NadK COG0061
NAD kinase [Coenzyme transport and metabolism];
1-87 8.34e-05

NAD kinase [Coenzyme transport and metabolism];


Pssm-ID: 439831 [Multi-domain]  Cd Length: 279  Bit Score: 43.59  E-value: 8.34e-05
                         10        20        30        40        50        60        70        80
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 495178532   1 MKKkaifiINLISGTSDKAAIP--ELIEQLLDKEKFEYEIAiTQYAGHASEIASKAKDAnvDLVVAVGGDGTVNEVARAI 78
Cdd:COG0061    1 MKR-----IAIVAKPGKPEALEaaEELAELLEERGIEVVLD-EDTAVPGVPLEELGEEA--DLVIVLGGDGTLLRAARLL 72
                         90
                 ....*....|
gi 495178532  79 VHSNTA-LGI 87
Cdd:COG0061   73 APLGIPiLGI 82
COG3199 COG3199
NAD kinase [Nucleotide transport and metabolism];
26-87 1.34e-04

NAD kinase [Nucleotide transport and metabolism];


Pssm-ID: 442432 [Multi-domain]  Cd Length: 367  Bit Score: 43.33  E-value: 1.34e-04
                         10        20        30        40        50        60
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*..
gi 495178532  26 EQLLDKEKFEYEIAITQYAGHAS-----EIASKAKDANVDLVVAVGGDGTVNEVARAIVHSNTALGI 87
Cdd:COG3199   68 EDVLRELGFEVEVLYDMPPVTTTaedtrRAARAMLEAGVDLIVFLGGDGTARDVAKAVGDSVPVLGI 134
PLN02204 PLN02204
diacylglycerol kinase
3-81 2.98e-04

diacylglycerol kinase


Pssm-ID: 215126 [Multi-domain]  Cd Length: 601  Bit Score: 42.56  E-value: 2.98e-04
                         10        20        30        40        50        60        70        80
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 495178532   3 KKAIFIINLISGTSDKAAIPELIEQLLDKEKFEYEIAITQYAGHASEIASKAKDANV---DLVVAVGGDGTVNEVARAIV 79
Cdd:PLN02204 160 KNLLVFVHPLSGKGSGSRTWETVSPIFIRAKVKTKVIVTERAGHAFDVMASISNKELksyDGVIAVGGDGFFNEILNGYL 239

                 ..
gi 495178532  80 HS 81
Cdd:PLN02204 240 LS 241
ppnK PRK01231
NAD(+) kinase;
9-87 4.27e-04

NAD(+) kinase;


Pssm-ID: 179257 [Multi-domain]  Cd Length: 295  Bit Score: 41.48  E-value: 4.27e-04
                         10        20        30        40        50        60        70        80
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 495178532   9 INLIsGTSDKAAIPELIEQLLDKEK-------FEYEIAITqYAGHASEIASKAKDANV-DLVVAVGGDGTVNEVARAIVH 80
Cdd:PRK01231   7 IGLI-GRLGSSSVVETLRRLKDFLLdrgleviLDEETAEV-LPGHGLQTVSRKLLGEVcDLVIVVGGDGSLLGAARALAR 84

                 ....*...
gi 495178532  81 SNTA-LGI 87
Cdd:PRK01231  85 HNVPvLGI 92
GlyDH-like cd08550
Glycerol_dehydrogenase-like; This family contains glycerol dehydrogenase (GlyDH)-like proteins. ...
11-78 5.15e-03

Glycerol_dehydrogenase-like; This family contains glycerol dehydrogenase (GlyDH)-like proteins. Glycerol dehydrogenases (GlyDH) is a key enzyme in the glycerol dissimilation pathway. In anaerobic conditions, many microorganisms utilize glycerol as a source of carbon through coupled oxidative and reductive pathways. One of the pathways involves the oxidation of glycerol to dihydroxyacetone with the reduction of NAD+ to NADH catalyzed by glycerol dehydrogenases. Dihydroxyacetone is then phosphorylated by dihydroxyacetone kinase and enters the glycolytic pathway for further degradation. The activity of GlyDH is zinc-dependent; the zinc ion plays a role in stabilizing an alkoxide intermediate at the active site. Some subfamilies have yet to be characterized.


Pssm-ID: 341480 [Multi-domain]  Cd Length: 347  Bit Score: 38.29  E-value: 5.15e-03
                         10        20        30        40        50        60        70
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....
gi 495178532  11 LISG-TSDKAAIPELIEQLlDKEKFEYEIAItqYAGHASE-----IASKAKDANVDLVVAVGGdGTVNEVARAI 78
Cdd:cd08550   27 IIGGkTALEAVGEKLEKSL-EEAGIDYEVEV--FGGECTEenierLAEKAKEEGADVIIGIGG-GKVLDTAKAV 96
Fe-ADH cd08551
iron-containing alcohol dehydrogenases (Fe-ADH)-like; This family contains large ...
18-78 6.01e-03

iron-containing alcohol dehydrogenases (Fe-ADH)-like; This family contains large metal-containing alcohol dehydrogenases (ADH), known as iron-containing alcohol dehydrogenases. They contain a dehydroquinate synthase-like protein structural fold and mostly contain iron. They are distinct from other alcohol dehydrogenases which contains different protein domains. There are several distinct families of alcohol dehydrogenases: Zinc-containing long-chain alcohol dehydrogenases, insect-type, or short-chain alcohol dehydrogenases, iron-containing alcohol dehydrogenases, among others. The iron-containing family has a Rossmann fold-like topology that resembles the fold of the zinc-dependent alcohol dehydrogenases, but lacks sequence homology, and differs in strand arrangement. ADH catalyzes the reversible oxidation of alcohol to acetaldehyde with the simultaneous reduction of NAD(P)+ to NAD(P)H.


Pssm-ID: 341481 [Multi-domain]  Cd Length: 372  Bit Score: 38.20  E-value: 6.01e-03
                         10        20        30        40        50        60
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*.
gi 495178532  18 KAAIPELIEQLLDKEKFEYEIaITQYAGHAS-----EIASKAKDANVDLVVAVGGdGTVNEVARAI 78
Cdd:cd08551   36 KAGLLDKVLESLKAAGIEVEV-FDDVEPNPTvetveAAAELAREEGADLVIAVGG-GSVLDTAKAI 99
 
Blast search parameters
Data Source: Precalculated data, version = cdd.v.3.21
Preset Options:Database: CDSEARCH/cdd   Low complexity filter: no  Composition Based Adjustment: yes   E-value threshold: 0.01

References:

  • Wang J et al. (2023), "The conserved domain database in 2023", Nucleic Acids Res.51(D)384-8.
  • Lu S et al. (2020), "The conserved domain database in 2020", Nucleic Acids Res.48(D)265-8.
  • Marchler-Bauer A et al. (2017), "CDD/SPARCLE: functional classification of proteins via subfamily domain architectures.", Nucleic Acids Res.45(D)200-3.
Help | Disclaimer | Write to the Help Desk
NCBI | NLM | NIH